Hepatocellulcar Carcinoma
3 clinical trials · Condition
◉ Watch Hepatocellulcar Carcinoma
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Comparison Between PD-1 Inhibitor Combined With Lenvatinib or With Regorafenib For UHCC After Failure of First-line Treatment (NCT07537985) | Sun Yat-sen University | 2020-01-01 |
Track Hepatocellulcar Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.